Pfizer (PFE) EBIT (2009 - 2026)
Pfizer's EBIT was $4.27 billion in Q2 2026, down 15.6% from $5.05 billion a year earlier and down 20.3% from the prior quarter.
Powered by 
Analysis
Pfizer (PFE) EBIT (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Pfizer's EBIT was $20.39 billion through Jun 28, 2026, up 1.5% year-over-year; for FY2025, it came in at $20.73 billion, up 16.4% from FY2024.
- EBIT shows a five-year compound annual growth rate of 11.0% (FY2020 to FY2025).
- In earlier years, EBIT was $17.81 billion in FY2024 (+186.9%), $6.21 billion in FY2023 (-84.6%), $40.35 billion in FY2022 (+51.7%) and $26.6 billion in FY2021 (+116.6%).
- The Q2 2026 figure marks the lowest quarterly EBIT since Q4 2024.
- Compared with a year earlier, EBIT was higher in four of the last six quarters, with growth averaging 19.8%.
- The best year-over-year quarter for EBIT over five years was Q3 2021 (growth of 137.5%); the worst was Q2 2023 (a decline of 73.8%).
- Per Business Quant data, PFE's EBIT in the three quarters before Q2 2026 was $5.35 billion (Q1 2026), $4.31 billion (Q4 2025) and $6.46 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Vertex Pharmaceuticals | 128.38 Bn | 100.39 Bn | 2.84 Bn | 1.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 4.27 Bn |
| Mar 29, 2026 | 5.35 Bn |
| Dec 31, 2025 | 4.31 Bn |
| Sep 28, 2025 | 6.46 Bn |
| Jun 29, 2025 | 5.05 Bn |
| Mar 30, 2025 | 4.96 Bn |
| Dec 31, 2024 | 3.80 Bn |
| Sep 29, 2024 | 6.28 Bn |
| Jun 30, 2024 | 2.32 Bn |
| Mar 31, 2024 | 5.41 Bn |
| Dec 31, 2023 | -2.95 Bn |
| Jul 2, 2023 | 3.41 Bn |
| Apr 2, 2023 | 7.72 Bn |
| Dec 31, 2022 | 5.23 Bn |
| Jul 3, 2022 | 13.04 Bn |
| Apr 3, 2022 | 10.59 Bn |
| Dec 31, 2021 | 3.83 Bn |
| Oct 3, 2021 | 7.88 Bn |
| Jul 4, 2021 | 6.75 Bn |
| Apr 4, 2021 | 5.57 Bn |
API Access
Pfizer EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=PFE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "PFE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=PFE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();